An aiHumanoid Simulation of Gram-Negative Sepsis: A Comprehensive Multi-Organoid Platform for Advanced Disease Modeling, Drug Discovery, and Personalized Medicine

Author:

Danter Wayne RORCID

Abstract

AbstractOrganoids are three-dimensional cellular structures resembling human organs, which have emerged as valuable tools for studying organ development, disease modeling, and drug discovery. Integrating multiple organoid systems allows for the examination of complex interactions between different organs. In this study, we present the development and initial validation of the aiHumanoid simulation, an advanced AI-based computational framework that integrates 18 individual organoid simulations through a common cardiovascular system. Our aim is to investigate the systemic effects of gram-negative sepsis, a life-threatening condition that affects multiple organ systems.In this study, we evaluated the impact of gram-negative sepsis on the organoid systems that make up the aiHumanoid simulation. Our findings indicate significant alterations in cardiovascular, nervous system, respiratory, renal, hepatic, hematologic, gastrointestinal, musculoskeletal, immune, and endocrine parameters in both male and female sepsis-affected organoids. Notably, markers of inflammation, coagulation, renal dysfunction, liver damage, immune response, and endocrine regulation were significantly affected by sepsis. While some parameters showed gender-specific differences in response, such as hormonal changes, the overall impact of gram-negative sepsis was observed in both sexes.This study demonstrates the potential of the aiHumanoid to accurately simulate the systemic effects of diseases on various organ systems. The integration of computational simulations with organoid systems offers a powerful approach for understanding disease mechanisms and evaluating potential therapies. By providing a more efficient and physiologically relevant platform for drug testing, the aiHumanoid simulation has the potential to accelerate the drug development process, reduce costs, and minimize the need for animal testing. Further research and ongoing validation will be crucial to fully exploit the capabilities of this revolutionary computational framework for advancing disease modeling and therapeutic interventions.

Publisher

Cold Spring Harbor Laboratory

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3